 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||
6 July 2004 | Volume 141 Issue 1 | Pages 47-56
Background: Previous meta-analyses demonstrated that high-dose glucocorticoids were not beneficial in sepsis. Recently, lower-dose glucocorticoids have been studied.
Purpose: To compare recent trials of glucocorticoids for sepsis with previous glucocorticoid trials.
Data Sources: Systematic MEDLINE search for studies published between 1988 and 2003.
Study Selection: Randomized, controlled trials of sepsis that examined the effects of glucocorticoids on survival or vasopressor requirements.
Data Extraction: Two investigators independently collected data on patient and study characteristics, treatment interventions, and outcomes.
Data Synthesis: The 5 included trials revealed a consistent and beneficial effect of glucocorticoids on survival (I2 = 0%; relative benefit, 1.23, [95% CI, 1.01 to 1.50]; P = 0.036) and shock reversal (I2 = 0%; relative benefit, 1.71 [CI, 1.29 to 2.26]; P < 0.001). These effects were the same regardless of adrenal function. In contrast, 8 trials published before 1989 demonstrated a survival disadvantage with steroid treatment (I2 = 14%; relative benefit, 0.89 [CI, 0.82 to 0.97]; P = 0.008). In comparison with the earlier trials, the more recent trials administered steroids later after patients met enrollment criteria (median, 23 hours vs. <2 hours; P = 0.02), for longer courses (6 days vs. 1 day; P = 0.01), and in lower total dosages (hydrocortisone equivalents, 1209 mg vs. 23 975 mg; P = 0.01) to patients with higher control group mortality rates (mean, 57% vs. 34%; P = 0.06) who were more likely to be vasopressor-dependent (100% vs. 65%; P = 0.03). The relationship between steroid dose and survival was linear, characterized by benefit at low doses and increasing harm at higher doses (P = 0.02).
Limitations: We could not analyze time-related improvements in medical care and potential bias secondary to nonreporting of negative study results.
Conclusions: Although short courses of high-dose glucocorticoids decreased survival during sepsis, a 5- to 7-day course of physiologic hydrocortisone doses with subsequent tapering increases survival rate and shock reversal in patients with vasopressor-dependent septic shock.
Author and Article Information
From the Clinical Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, and Massachusetts General Hospital, Boston, Massachusetts.
Note: Drs. Minneci and Deans contributed equally to the creation of this manuscript; the order of their names is arbitrary.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Peter C. Minneci, MD, Critical Care Medicine Department, National Institutes of Health, 10 Center Drive, Building 10, Room 7D43, Bethesda, MD 20892; e-mail, pminneci{at}mail.cc.nih.gov.
Current Author Addresses: Drs. Minneci, Deans, Banks, Eichacker, and Natanson: Critical Care Medicine Department, National Institutes of Health, 10 Center Drive, Building 10, Room 7D43, Bethesda, MD 20892. REVIEW
Meta-Analysis: The Effect of Steroids on Survival and Shock during Sepsis Depends on the Dose
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. Gotoh, N. Nishimura, O. Takahashi, H. Shiratsuka, H. Horinouchi, H. Ono, N. Uchiyama, and N. Chohnabayashi Adrenal function in patients with community-acquired pneumonia Eur. Respir. J., June 1, 2008; 31(6): 1268 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Daley, N. Seam, R. Luboshitzky, G. Qupti, P.-E. Bollaert, P. E. Marik, S. M. Pastores, B. P. Kavanagh, S. Manoach, C. L. Sprung, et al. Corticosteroids for Septic Shock N. Engl. J. Med., May 8, 2008; 358(19): 2068 - 2071. [Full Text] [PDF]
|
|
|
|
|
|
C. L. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer, K. Freivogel, Y. G. Weiss, J. Benbenishty, A. Kalenka, H. Forst, et al. Hydrocortisone Therapy for Patients with Septic Shock N. Engl. J. Med., January 10, 2008; 358(2): 111 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Finfer Corticosteroids in Septic Shock N. Engl. J. Med., January 10, 2008; 358(2): 188 - 190. [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Cotton, O. D. Guillamondegui, S. B. Fleming, R. O. Carpenter, S. H. Patel, J. A. Morris Jr, and P. G. Arbogast Increased Risk of Adrenal Insufficiency Following Etomidate Exposure in Critically Injured Patients Arch Surg, January 1, 2008; 143(1): 62 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Wheeler Recent Developments in the Diagnosis and Management of Severe Sepsis Chest, December 1, 2007; 132(6): 1967 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Cooper and P. M. Stewart Adrenal Insufficiency in Critical Illness J Intensive Care Med, November 1, 2007; 22(6): 348 - 362. [Abstract] [PDF]
|
|
|
|
 |
|
 J. V. Maier, S. Brema, J. Tuckermann, U. Herzer, M. Klein, M. Stassen, A. Moorthy, and A. C. B. Cato Dual Specificity Phosphatase 1 Knockout Mice Show Enhanced Susceptibility to Anaphylaxis but Are Sensitive to Glucocorticoids Mol. Endocrinol., November 1, 2007; 21(11): 2663 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. U. Meduri There Is No Illumination in Speculation: Additional Data in Support of Methylprednisolone Treatment in ARDS Chest, September 1, 2007; 132(3): 1097 - 1100. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Thomas and G. L Fraser An Update on the Diagnosis of Adrenal Insufficiency and the Use of Corticotherapy in Critical Illness Ann. Pharmacother., September 1, 2007; 41(9): 1456 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. U. Meduri, E. Golden, A. X. Freire, E. Taylor, M. Zaman, S. J. Carson, M. Gibson, and R. Umberger Methylprednisolone Infusion in Early Severe ARDS*Results of a Randomized Controlled Trial Chest, April 1, 2007; 131(4): 954 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. de Kruif, L. C. Lemaire, I. A. Giebelen, M. A. D. van Zoelen, J. M. Pater, P. S. van den Pangaart, A. P. Groot, A. F. de Vos, P. J. Elliott, J. C. M. Meijers, et al. Prednisolone Dose-Dependently Influences Inflammation and Coagulation during Human Endotoxemia J. Immunol., February 1, 2007; 178(3): 1845 - 1851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vanhorebeek, R. P. Peeters, S. Vander Perre, I. Jans, P. J. Wouters, K. Skogstrand, T. K. Hansen, R. Bouillon, and G. Van den Berghe Cortisol Response to Critical Illness: Effect of Intensive Insulin Therapy J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3803 - 3813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Suri, J. Moran, J. U. Hibbard, K. Kasza, and R. E. Weiss Assessment of Adrenal Reserve in Pregnancy: Defining the Normal Response to the Adrenocorticotropin Stimulation Test J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3866 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Marik, D. Annane, C. L. Sprung, W. Arlt, D. Keh, and for the International Task Force on the Diagnoses Using Corticosteroids in Intensive Care Arch Surg, September 1, 2006; 141(9): 946 - 947. [Full Text] [PDF]
|
|
|
|
 |
|
 C. VELLOZZI, T. MITCHELL, E. MILLER, C. G. CASEY, R. B. EIDEX, E. B. HAYES, and THE YELLOW FEVER VACCINE SAFETY WORKING GROUP YELLOW FEVER VACCINE-ASSOCIATED VISCEROTROPIC DISEASE (YEL-AVD) AND CORTICOSTEROID THERAPY: ELEVEN UNITED STATES CASES, 1996-2004. Am J Trop Med Hyg, August 1, 2006; 75(2): 333 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Arlt, F. Hammer, P. Sanning, S. K. Butcher, J. M. Lord, B. Allolio, D. Annane, and P. M. Stewart Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2548 - 2554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Liu, M. A. Matthay, and G. M. Chertow Evolving Practices in Critical Care and Potential Implications for Management of Acute Kidney Injury Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 869 - 873. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nonas, I. Miller, K. Kawkitinarong, S. Chatchavalvanich, I. Gorshkova, V. N. Bochkov, N. Leitinger, V. Natarajan, J. G. N. Garcia, and K. G. Birukov Oxidized Phospholipids Reduce Vascular Leak and Inflammation in Rat Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1130 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Talwar, P. J. Munson, J. Barb, C. Fiuza, A. P. Cintron, C. Logun, M. Tropea, S. Khan, D. Reda, J. H. Shelhamer, et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans Physiol Genomics, April 13, 2006; 25(2): 203 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Vincent and E. Abraham The Last 100 Years of Sepsis Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 256 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Harrison Prospects for Vaccine Prevention of Meningococcal Infection Clin. Microbiol. Rev., January 1, 2006; 19(1): 142 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Ho, H. Al-Musalhi, M. J. Chapman, T. Quach, P. D. Thomas, C. J. Bagley, J. G. Lewis, and D. J. Torpy Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 105 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wartofsky Update in Endocrinology Ann Intern Med, November 1, 2005; 143(9): 673 - 682. [Full Text] [PDF]
|
|
|
|
|
|
G. U. Meduri, R. Umberger, and M. Confalonieri Hydrocortisone Infusion for Severe Community-acquired Pneumonia: The Role of Relative Adrenal Insufficiency Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 782 - 783. [Full Text] [PDF]
|
|
|
|
|
|
G. Dickstein On the Term "Relative Adrenal Insufficiency"--or What Do We Really Measure with Adrenal Stimulation Tests? J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4973 - 4974. [Full Text] [PDF]
|
|
|
|
 |
|
 ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., April 1, 2005; 10(2): 62 - 62. [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Munford Invited review: Detoxifying endotoxin: time, place and person Innate Immunity, April 1, 2005; 11(2): 69 - 84. [Abstract] [PDF]
|
|
|
|
|
|
M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi, G. Puccio, R. Della Porta, C. Giorgio, F. Blasi, R. Umberger, et al. Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 242 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N Bower and L. J Oyen Interaction Between Dexamethasone Treatment and the Corticotropin Stimulation Test in Septic Shock Ann. Pharmacother., February 1, 2005; 39(2): 335 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Noble Dose Effects of Steroids on Survival in Sepsis Ann Intern Med, December 7, 2004; 141(11): 891 - 891. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Badgett Dose Effects of Steroids on Survival in Sepsis Ann Intern Med, December 7, 2004; 141(11): 891 - 892. [Full Text] [PDF]
|
|
|
|
|
|
P. C. Minneci, K. J. Deans, S. M. Banks, P. Q. Eichacker, and C. Natanson Corticosteroids for Septic Shock Ann Intern Med, November 2, 2004; 141(9): 742 - 743. [Full Text] [PDF]
|
|
|
|
|
|
Other articles noted Evid. Based Med., November 1, 2004; 9(6): 191 - 192. [Full Text] [PDF]
|
|
|
|
 |
|
 Steroids in Sepsis: The Fog Is Beginning to Lift Journal Watch Emergency Medicine, July 28, 2004; 2004(728): 2 - 2. [Full Text]
|
|
|
|
|
|
J. M. Luce Physicians Should Administer Low-Dose Corticosteroids Selectively to Septic Patients until an Ongoing Trial Is Completed Ann Intern Med, July 6, 2004; 141(1): 70 - 72. [Full Text] [PDF]
|
|
Read all Rapid Responses
Article
